Skip to main content

Drug and Gene Electrotransfer to the Brain

  • Chapter
  • First Online:

Abstract

Applying drugs and genes to brain tissue using electroporation is a new and upcoming field of research. Because of the blood brain barrier (BBB), the access of agents from the blood into brain tissue is restricted. This could theoretically be overcome by the use of electroporation. In the early 1990s, the first pre-clinical experiments using electrochemotherapy in brain tissue were conducted in rats with inoculated brain tumours; however, the technique has not yet been further explored and applied in humans. This chapter will focus on the pre-clinical experience with drug and gene electrotransfer in the brain, the clinical experience with use of bleomycin in the brain, and the following clinical perspectives. Further discussion of central issues, such as safety and the BBB, will also be discussed.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Videtic GM, Gaspar LE, Aref AM, et al. American College of Radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys. 2009;75(4):961–5.

    Article  PubMed  Google Scholar 

  2. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol. 2005;12 Suppl 1:1–27.

    Article  PubMed  Google Scholar 

  3. Burton EA, Glorioso JC, Fink DJ. Gene therapy progress and prospects: Parkinson’s disease. Gene Ther. 2003;10(20):1721–7.

    Article  PubMed  CAS  Google Scholar 

  4. Christine CW, Starr PA, Larson PS, et al. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology. 2009;73(20):1662–9.

    Article  PubMed  CAS  Google Scholar 

  5. Orlowski S, Belehradek Jr J, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol. 1988;37(24):4727–33.

    Article  PubMed  CAS  Google Scholar 

  6. Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs. 1998;9(4):319–25.

    Article  PubMed  CAS  Google Scholar 

  7. Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs. 2000;11(3):201–8.

    Article  PubMed  CAS  Google Scholar 

  8. Salford LG, Persson BR, Brun A, Ceberg CP, Kongstad PC, Mir LM. A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun. 1993;194(2):938–43.

    Article  PubMed  CAS  Google Scholar 

  9. Larsen BA, Iversen H, Ibsen P, et al. Electrochemotherapy for brain tumors investigated in vivo. Neuro Oncol. 2009;11(5):597.

    Google Scholar 

  10. De Vita V, Hellmann S, Rosenberg S. Cancer, principles and practice of oncology. 5th ed. Philadelphia, PA: Lippincott-Raven; 1993.

    Google Scholar 

  11. Kondoh T, Motooka Y, Bhattacharjee AK, Kokunai T, Saito N, Tamaki N. In vivo gene transfer into the periventricular region by electroporation. Neurol Med Chir. 2000;40(12):618–22.

    Article  CAS  Google Scholar 

  12. Wang H, Ko CH, Koletar MM, Ralph MR, Yeomans J. Casein kinase I epsilon gene transfer into the suprachiasmatic nucleus via electroporation lengthens circadian periods of tau mutant hamsters. Eur J Neurosci. 2007;25(11):3359–66.

    Article  PubMed  Google Scholar 

  13. Nishi T, Yoshizato K, Yamashiro S, et al. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res. 1996;56(5):1050–5.

    PubMed  CAS  Google Scholar 

  14. Linnert M, Gehl J. Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs. 2009;20(3):157–64.

    Article  PubMed  CAS  Google Scholar 

  15. Poddevin B, Orlowski S, Belehradek J, Mir LM. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol. 1991;42:S67–75.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julie Gehl .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Agerholm-Larsen, B., Linnert, M., Iversen, H.K., Gehl, J. (2011). Drug and Gene Electrotransfer to the Brain. In: Kee, S., Gehl, J., Lee, E. (eds) Clinical Aspects of Electroporation. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-8363-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-8363-3_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-8362-6

  • Online ISBN: 978-1-4419-8363-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics